FT US Equity Buffer ETF - July
| Issuer: First Trust |
| Asset Class: Risk-Controlled |
| TER: 85bps |
| Trading Currency: GBX |
| Pays Income: False |
| Listing Date: 21 Jul 2025 |
| Ticker: JULF |
| ISIN: IE000YJBT6I5 |
This actively managed fund offers a defined outcome strategy for investors seeking exposure to the performance of large-cap U.S. equities, specifically mirroring the price returns of the SPDR S&P 500 ETF Trust. The investment approach is tailored for those who are willing to forgo some upside potential in exchange for a measure of downside protection. The fund aims to shield investors from the first 10% of losses incurred by the underlying equity exposure over a one-year target outcome period, which resets annually in July. This "buffer" provides a significant cushion against moderate market downturns, making it a potentially attractive option for more risk-averse equity investors or during periods of anticipated market volatility.
In return for this downside protection, the fund's potential gains are capped at a pre-determined level. This cap is set at the beginning of each target outcome period and represents the maximum return an investor can achieve, even if the underlying equities perform better. The strategy is implemented through a portfolio of FLexible Exchange® Options (FLEX Options), which are customized option contracts on the reference ETF. It is important for investors to understand that the defined outcomes—the buffer and the cap—are applicable only to those who hold the shares for the entire one-year period.
The fund is designed for investors looking for a middle ground between full equity market participation and holding cash or fixed income. It allows for upside participation while mitigating a specific slice of the downside risk. However, investors are still exposed to losses that exceed the 10% buffer. The defined outcome nature of the investment means its performance characteristics are distinct from a direct investment in the underlying equities, providing a unique risk-return profile that can complement a diversified portfolio.
